Why did OSX.AX stock spike pre-market today?

The pre-market spike to A$0.012 reflected a surge in volume (11,944,649 shares) and short-term buying momentum. No single public announcement explains the move; traders often react to order flow, news leaks, or speculative interest in micro-caps.

What is Meyka AI's forecast for OSX.AX stock?

Meyka AI's forecast model projects a quarterly price of A$0.080 for OSX.AX stock, implying a model-based upside of 566.67% from A$0.012. Forecasts are model-based projections and not guarantees.

What are the main risks when trading OSX.AX stock?

Key risks include low market capitalisation (A$3.39M), thin liquidity, negative operating cash flow per share, potential dilution, and high technical overbought readings. Use strict position sizing and stop-losses.

When is the next earnings announcement for OSX.AX stock?

Osteopore has an earnings announcement scheduled for 26 Feb 2026. Traders should monitor that release and management commentary for revenue visibility and cash flow updates ahead of further moves.

AU Stocks

OSX.AX jumps 71% pre-market to A$0.012 20 Jan 2026: watch A$0.08 model target

ByDanny Kontos January 20, 2026

OSX.AX stock opened sharply higher pre-market on 20 Jan 2026 after a surge in trading volume. Osteopore Limited (OSX.AX) rose to A$0.012, up 71.43%, on 11,944,649 shares traded versus an average of 3,495,386. This high-volume move highlights short-term momentum in the ASX Healthcare micro-cap and demands attention from traders watching liquidity and model-driven targets.